The Global BCG Vaccines Sales Market was valued at $45 million in 2017, and is estimated to reach $65 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.
BCG vaccine is a live attenuated vaccine used for the prevention of tuberculosis. It is administered to newborns from tuberculosis and leprosy prevalent regions. This vaccine is generally administered to children at birth in countries with high incidence of TB. However, in low incidence regions, only children at high risk are typically immunized, whereas adults are generally not immunized. However, adults (up to the age of 35) who are frequently exposed to drug-resistant TB may also be given BCG vaccine.
Major factors that drive the market growth are increase in the prevalence of tuberculosis and rise in technological advancements in vaccine research. Moreover, increase in government initiatives and focus on immunization programs globally boost the market growth. However, side-effects and a global shortage of BCG vaccine restrain the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market development.
This report segments the BCG vaccines sales market based on drug type, usage, end user, and region to provide a detailed assessment of the market. Based on drug type, it is bifurcated into immune BCG and therapy BCG. On the basis of usage, the market is categorized into tuberculosis and bladder cancer. Based on end user, it is segmented into adults and pediatrics. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Get Sample Copy of this Report@ https://www.bigmarketresearch.com/request-sample/3138283?utm_source=ir&utm_medium=geeta
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the BCG vaccines sales market along with the current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2017 to 2025 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
In-depth analysis of BCG vaccines sales based on drug type such as immune BCG and therapy BCG is carried out in the report.
The global BCG vaccines sales market scenario is comprehensively analyzed in accordance to the key cities.
KEY MARKET SEGMENTS
By Drug Type
- Immune BCG
- Therapy BCG
- Bladder Cancer
By End User
- North America
o Rest of Europe
o Rest of Asia-Pacific
o Latin America
o Middle East
Get a discount on this research report @ https://www.bigmarketresearch.com/request-for-discount/3138283?utm_source=ir&utm_medium=geeta
LIST OF KEY PLAYERS PROFILED IN THE REPORT (DEVICE PROVIDERS)
- AJ Vaccines
- China National Pharmaceutical Group Corporation (Sinopharm)
- Greensignal Bio Pharma Limited
- Intervax Ltd
- Japan BCG Laboratory
- Merck & Company Inc
- Sanofi S.A
- Serum Institute of India Pvt. Ltd
- Statens Serum Institute
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
- Shanyao Group
- Shanghai Institute of Biological Products
- BCG Vaccine Laboratory India
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
Mr. Abhishek Paliwal
Big Market Research
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Toll Free: +1-800-910-6452